A different non-viral approach was to combine a plasmid carrying CFTR gene with polyethylene glycol (PEG)-substituted 30-mer lysine polymers to form DNA nanoparticles that were administered to CF patient’s nostrils. The gene discussed is CFTR; the disease is cystic fibrosis.